高等学校化学研究 ›› 2011, Vol. 27 ›› Issue (1): 54-59.
WANG Shi-hui1, WANG Yan1, ZHU Yu-ying1, LIU Si-jie1, HAN Jian1, ZHOU Yi-fan1, LI Da-wei2, KOIRALA Diwa2 and HU Chun1*
WANG Shi-hui1, WANG Yan1, ZHU Yu-ying1, LIU Si-jie1, HAN Jian1, ZHOU Yi-fan1, LI Da-wei2, KOIRALA Diwa2 and HU Chun1*
摘要: Based on the principles of the bioisosterism, combination of the active substructures of selective estrogen receptor modulators which are currently therapeutic agents available for the prevention and treatment of various estrogen dependent diseases, and structural optimization, a novel series of 2-aroyl-3-aryl-6,7-dihydro-5H-furo[3,2-g]-chromen derivatives was designed as potent selective estrogen receptor modulators via molecular docking. The target compounds have been synthesized, and characterized by IR, proton NMR, ESI-MS, elemental analysis and evaluated for their antitumor activity against human osteosarcoma U2OS-EGFP-4F12G cell line. Some target compounds showed good inhibition effects on U2OS-EGFP-4F12G cell line and the preliminary structure-activity relationships were discussed.